Autopsy report · NCT04459299

CorPath GRX STEMI Study

“Low enrollment and sponsor business decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Siemens Healthineers Endovascular Robotics, Inc.

Sponsor type

Industry

Conditions

STEMI - ST Elevation Myocardial Infarction; CAD

Interventions

Robotic-PCI (CorPath GRX System)

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• A Clinical Investigation Evaluating Peristeen® Performance
  “Lack of enrollment - Sponsor decision” (85% match in meaning)
• Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
  “Sponsor decision due to lack of enrollment.” (81% match in meaning)
• Digital Remote Home Monitoring for Heart Failure
  “Due to sponsor request for poor enrollment” (76% match in meaning)
• ALgorithms Adapted From Remote Monitoring
  “Low enrollment, completion of funding” (76% match in meaning)
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults
  “Business Decision (no enrollment)” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.